<DOC>
	<DOCNO>NCT02978157</DOCNO>
	<brief_summary>From profile antibiotic susceptibility data follow eradication therapy , tetracycline , amoxicillin levofloxacin good candidate antibiotic use rescue treatment .</brief_summary>
	<brief_title>Levofloxacin Triple Bismuth Quadruple Therapies Rescue Treatment H Pylori Infection</brief_title>
	<detailed_description>The H pylori-infected adult patient failure standard triple therapy H pylori-infected adult patient failure non-bismuth quadruple therapy randomly assign either EAL ( esomeprazole 40 mg b.d. , amoxicillin 500 mg q.d.s. , levofloxacin 500 mg o.d . ) EBTL ( esomeprazole 40 mg b.d. , bismuth 500 mg q.d.s. , tetracycline 500 mg q.d.s. , levofloxacin 500 mg o.d . ) therapy 10 day . Repeated endoscopy rapid urease test , histological examination culture urea breath test perform six week end anti-H pylori therapy .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<criteria>positive result rapid urease test histology , positive result urea breath test , positive result culture . ingestion antibiotic , bismuth , proton pump inhibitor（PPI）within prior 4 week , patient allergic history medication use , patient previous gastric surgery , coexistence serious concomitant illness ( example , decompensated liver cirrhosis , uremia ) , pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Eradication rate</keyword>
	<keyword>Rescue treatment</keyword>
</DOC>